SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 13, 1997
COPLEY PHARMACEUTICAL, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or other jurisdiction of incorporation or organization)
0-20126 04-2514637
(Commission File Number) (IRS Employer Identification No.)
25 John Road
Canton, Massachusetts 02021
(Address of principal executive offices) (Zip Code)
(617) 821-6111
(Registrant's telephone number, including area code)
<PAGE 2>
Item 5. Other Events
On January 13, 1997, Copley Pharmaceutical, Inc. (the "Company") announced
that Kenneth N. Larsen has retired as President for health reasons. Mr. Larsen
will continue to serve on the Board of Directors and will remain its Chairman.
Mr. Larsen has been the Company's President since July of 1996, a member
of Copley's Board of Directors since 1989, and also served as a member of the
Board from September 1985 to November 1986. A well-known member of management
and advisor to numerous health-care companies over his 49 year career, Mr.
Larsen was also a founding member and initial chairman of the Generic
Pharmaceutical Industry Association.
The Company has not named a replacement.
<PAGE 3>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
January 13, 1997
COPLEY PHARMACEUTICAL, INC.
/s/ Ken E. Starkweather
______________________________
Ken E. Starkweather
Vice President - Finance
Principal Financial Officer
